|
C5ORF28 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.31889998922219E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.88110000021169E-07 |
| Normal-vs-Stage2 |
3.430300E-02 |
| Normal-vs-Stage3 |
3.186000E-01 |
| Normal-vs-Stage4 |
2.910200E-01 |
| Stage1-vs-Stage2 |
6.780200E-01 |
| Stage1-vs-Stage3 |
2.399200E-03 |
| Stage1-vs-Stage4 |
4.972800E-01 |
| Stage2-vs-Stage3 |
8.989800E-02 |
| Stage2-vs-Stage4 |
4.766000E-01 |
| Stage3-vs-Stage4 |
5.092200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.03470000345496E-08 |
| Normal-vs-AfricanAmerican |
1.496950E-03 |
| Normal-vs-Asian |
4.760600E-01 |
| Caucasian-vs-AfricanAmerican |
3.768000E-01 |
| Caucasian-vs-Asian |
4.518400E-01 |
| AfricanAmerican-vs-Asian |
6.125600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.04659997230061E-09 |
| Normal-vs-Female |
4.010000E-04 |
| Male-vs-Female |
5.502600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.555800E-03 |
| Normal-vs-Extreme_Weight |
1.75451999999687E-05 |
| Normal-vs-Obese |
2.180600E-04 |
| Normal-vs-Extreme_Obese |
4.434400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.680600E-01 |
| Normal_Weight-vs-Obese |
8.210800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.010800E-01 |
| Extreme_Weight-vs-Obese |
3.931000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.927800E-02 |
| Obese-vs-Extreme_Obese |
2.595400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.315600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.56299999504373E-08 |
| Normal-vs-Age(61-80Yrs) |
1.55960000000066E-05 |
| Normal-vs-Age(81-100Yrs) |
4.605800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.440800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.224200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.585000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.738000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.643800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.078000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.65534252971611E-12 |
| Normal-VS-Type2 PRCC |
9.714400E-01 |
| Normal-VS-KIRP CIMP |
4.018200E-01 |
| Normal-VS-Unclassified PRCC |
3.560500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.44071429733594E-12 |
| Type1 PRCC-VS-KIRP CIMP |
5.89340000000105E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.572190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.965000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.201700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.959700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.660300E-02 |
| Normal-vs-N1 |
2.211600E-01 |
| Normal-vs-N2 |
4.440200E-01 |
| N0-vs-N1 |
7.394600E-01 |
| N0-vs-N2 |
3.179400E-01 |
| N1-vs-N2 |
4.164400E-01 |
|
|
